Skip to main content

Jasinski Lawrence J's Form 4 filing

Lemaitre Vascular Inc (LMAT) · filed May 11, 2026

Accession no.
0001193125-26-217096
Filed
May 11, 2026
Trade date
May 7, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $433.7K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jasinski Lawrence JCIK 0001366346Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 7, 2026Common StockMOption exerciseAcquired+1,069$47.19+$50,446.116,868Direct
May 7, 2026Common StockMOption exerciseAcquired+924$54.65+$50,496.67,792Direct
May 7, 2026Common StockMOption exerciseAcquired+865$101.12+$87,468.88,657Direct
May 7, 2026Common StockSSaleDisposed−3,943$110.00−$433,7304,714Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 7, 2026Common StockMOption exerciseDisposed−1,069$0.00$02,140Direct
May 7, 2026Common StockMOption exerciseDisposed−924$0.00$01,848Direct
May 7, 2026Common StockMOption exerciseDisposed−865$0.00$01,729Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)